CRI Worldwide, LLC - Kirkbride Division — Philadelphia, Pennsylvania

CRI Worldwide, LLC - Kirkbride Division is a clinical research site located in Philadelphia, Pennsylvania, United States 19139.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

CRI Worldwide, LLC - Kirkbride Division has participated in 2 clinical trials.

Therapeutic areas: Schizophrenia, Major Depressive Disorder.

Sponsors: Novartis, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CRI Worldwide, LLC - Kirkbride Division?

CRI Worldwide, LLC - Kirkbride Division has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CRI Worldwide, LLC - Kirkbride Division conducted?

CRI Worldwide, LLC - Kirkbride Division has 2 clinical trials on record. Their work covers Schizophrenia, Major Depressive Disorder.

Is CRI Worldwide, LLC - Kirkbride Division accredited by Crixeo Health?

CRI Worldwide, LLC - Kirkbride Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CRI Worldwide, LLC - Kirkbride Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.